Entering the Rapidly Evolving Nevada Market: Currently Generates $650,000 of Revenue per Month LAS VEGAS, NV / ACCESSWIRE, CLSH, / December 4, 2017 / CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a development stage diversified cannabis company operating as Cannabis Life Science, announced today an update to its previously announced non-binding Letter of Intent (“LOI”) to acquire a fully integrated cannabis operation in Nevada. Las Vegas-based Oasis Cannabis’ (http://oasiscannabis.com) operations include a grow, extraction and conversion processing and a retail dispensary. CLSRead more
- Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
- PHI Group Partners with Fintech Green Investment Company
- Third and Fourth Quarters 2018 Expected to See Continued Advancements for the Pura Natural’s Grease Beast Products Amid Approval as an Available Vendor to All True Value and Ace Hardware Stores
- Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
- Wrap Technologies Secures First Patent – Recaps IP Strategy
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More